Not Tagged
Not Tagged
['solid tumor']
#asco23 | hall a | saturday 8am ct
blu-222, an oral, potent, and selective cdk2 inhibitor, in patients with advanced solid tumors: phase 1 monotherapy dose escalation
dejan juric, md #mgccatasco23 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.